quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:07·1579d
SECFiling
Capstar Special Purpose Acquisition Corp. logo

SEC Form EFFECT filed by Capstar Special Purpose Acquisition Corp.

CPSR· Capstar Special Purpose Acquisition Corp.
Finance
Original source

Companies

  • CPSR
    Capstar Special Purpose Acquisition Corp.
    Finance

Related

  • PR1338d
    PureTech Health plc – Half-Year Report
  • PR1450d
    PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
  • PR1455d
    PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
  • PR1459d
    PureTech Announces Annual Results for Year Ended December 31, 2021
  • INSIDER1556d
    SEC Form 4: Cavanaugh Kathryn converted options into 12,825 shares, disposed of 12,825 shares and acquired 12,825 shares
  • SEC1560d
    SEC Form 25-NSE filed by Capstar Special Purpose Acquisition Corp.
  • NEWS1560d
    Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today
  • PR1560d
    PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022